QUESTION
IS THE FOLLOWING STATEMENT TRUE OR FALSE?
MENINGITIS IS AN INFLAMMATION OF THE PIA MATER, THE ARACHNOID, AND THE CEREBROSPINAL FLUID–FILLED SUBARACHNOID SPACE
ANSWER
TRUE
MENINGITIS IS AN INFLAMMATION OF THE PIA MATER, THE ARACHNOID, AND THE CEREBROSPINAL FLUID–FILLED SUBARACHNOID SPACE.
MENINGITIS
• INFLAMMATION OF THE MEMBRANES AND THE FLUID SPACE SURROUNDING THE BRAIN AND SPINAL CORD
• TYPES• SEPTIC CAUSED BY BACTERIA (STREPTOCOCCUS PNEUMONIAE, NEISSERIA
MENINGITIDIS)• ASEPTIC CAUSED BY VIRAL INFECTION, LYMPHOMA, LEUKEMIA, OR BRAIN ABSCESS
• N. MENINGITIDIS IS TRANSMITTED BY SECRETIONS OR AEROSOL CONTAMINATION, AND INFECTION IS MOST LIKELY IN DENSE COMMUNITY GROUPS SUCH AS COLLEGE CAMPUSES
• MANIFESTATIONS INCLUDE HEADACHE, FEVER, CHANGES IN LOC, BEHAVIORAL CHANGES, NUCHAL RIGIDITY (STIFF NECK), POSITIVE KERNIG'S SIGN, POSITIVE BRUDZINSKI’S SIGN, AND PHOTOPHOBIA
MENINGITIS
• INFLAMMATION OF THE LINING AROUND THE BRAIN AND SPINAL CORD• CAUSED BY BACTERIA OR VIRUS• 80% ARE CAUSED BY THE BACTERIA STREPTOCOCCUS PNEUMONIAE AND
NEISSERIA MENINGITIDES
• VIRAL INFECTIONS ARE USUALLY CAUSED BY MUMPS, HERPES, OR MOSQUITOES OR OTHER INSECTS.
MEDICAL MANAGEMENT
• PREVENTION BY VACCINATION AGAINST HAEMOPHILUS INFLUENZAE AND S. PNEUMONIAE FOR ALL CHILDREN AND ALL AT-RISK ADULTS
• PREVENTION BY MENINGOCOCCAL VACCINATION FOR ADOLESCENTS AND HIGH-RISK GROUPS
• EARLY ADMINISTRATION OF HIGH DOSES OF APPROPRIATE IV ANTIBIOTICS FOR BACTERIAL MENINGITIS
• DEXAMETHASONE • TREATMENT DEHYDRATION, SHOCK, AND SEIZURES
NURSING MANAGEMENT
• FREQUENT OR CONTINUAL ASSESSMENT, INCLUDING VS AND LOC• PROTECT PATIENT FORM INJURY RELATED TO SEIZURE ACTIVITY OR ALTERED LOC• MONITOR DAILY WEIGHT, SERUM ELECTROLYTES, URINE VOLUME, SPECIFIC GRAVITY,
AND OSMOLALITY• PREVENT COMPLICATIONS ASSOCIATED WITH IMMOBILITY • INFECTION CONTROL PRECAUTIONS• SUPPORTIVE CARE• MEASURES TO FACILITATE COPING OF PATIENT AND FAMILY
CEREBROSPINAL FLUID
Parameter Normal CSF Bacterial Meningitis
Viral Meningitis
Fungal Meningitis
Opening pressure (mm H20)
100-180 200-500 <250 >200
Leukocyte count (WBC/mm3)
0-5 Increased 100-5,000
Increased 50-1000
Increased > 20
Neutrophils (%) 0 > 80 < 40
Protein (mg/dL) 18-45 Elevated 100-500
Elevated < 200 Elevated > 45
Glucose 45-80; 0.6 times blood glucose level
5-40; < 0.3 times blood glucose level
> 45 < 40
INTERVENTIONS
• PROTECT CLIENTS
• EDUCATE CLIENTS
• MAINTAIN OWN WORKER HEALTH
• GIVE ANTIMICROBIALS
• BE AWARE OF S&S OF INFECTION
• PRACTICE MEDICAL AND SURGICAL ASEPSIS
COMPLICATIONS
• VISION AND HEARING IMPAIRMENTS• SEIZURES• HYDROCEPHALUS• PARALYSIS• SEPTIC SHOCK• BRAIN DAMAGE
POPULATIONS AT RISK AND SEASONS FOR OCCURRENCE OF MENINGITIS
Community Groups
Day Care/Schools
College Campuses
Military Installations
Winter Early Spring
FACTORS THAT INCREASE RISK
Smoking Viral Upper Respiratory Infection
Otitis Media Immune System Deficiencies
ASSESSMENT AND DIAGNOSTIC FINDINGS
• CT SCAN• MRI• LP FOR SPINAL FLUID ANALYSIS• BEDSIDE RISK SCORE; OF R EXAMPLE, UNFAVORABLE OUTCOMES: OLD AGE,
HR > 120/MIN, DECREASED GCS, CRANIAL NERVE PALSIES, AND A GRAM POSITIVE STAIN ONE HOUR AFTER HOSPITALIZATION
NURSES ROLE IN PREVENTION
• CDC RECOMMENDATIONS• MENINGOCOCCAL CONJUGATED VACCINE GIVEN AGE OF 11-12 YEARS AND A
BOOSTER AT 16 YEARS• EDUCATION ON MENINGITIS• AVAILABILITY OF VACCINE• PEOPLE IN CONTACT WITH MENINGITIS SHOULD RECEIVE RIFAMPIN, CIPRO,
OR ROCEPHIN THIS SHOULD BE STARTED 24 HOURS AFTER EXPOSURE